These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics. Ünal S; Doğan O; Aktaş Y Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636 [TBL] [Abstract][Full Text] [Related]
3. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
5. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of clarithromycin loaded PLGA nanoparticles. Valizadeh H; Mohammadi G; Ehyaei R; Milani M; Azhdarzadeh M; Zakeri-Milani P; Lotfipour F Pharmazie; 2012 Jan; 67(1):63-8. PubMed ID: 22393833 [TBL] [Abstract][Full Text] [Related]
8. Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Venkatesh DN; Baskaran M; Karri VV; Mannemala SS; Radhakrishna K; Goti S Saudi Pharm J; 2015 Nov; 23(6):667-74. PubMed ID: 26702262 [TBL] [Abstract][Full Text] [Related]
9. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis. Öztürk AA; Namlı İ; Güleç K; Kıyan HT Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668 [TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations. Salama AH; Mahmoud AA; Kamel R AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles. Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Cell Proliferation and Wound Healing Effects of Vitamin A Palmitate-Loaded PLGA/Chitosan-Coated PLGA Nanoparticles: Preparation, Characterization, Release, and Release Kinetics. Baghirova L; Kaya Tilki E; Öztürk AA ACS Omega; 2023 Jan; 8(2):2658-2668. PubMed ID: 36687101 [TBL] [Abstract][Full Text] [Related]
13. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil. Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982 [TBL] [Abstract][Full Text] [Related]
14. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
15. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610 [TBL] [Abstract][Full Text] [Related]
16. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446 [TBL] [Abstract][Full Text] [Related]
17. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
18. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells]. Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242 [TBL] [Abstract][Full Text] [Related]
19. Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery. Lu B; Lv X; Le Y Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960288 [TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells. Alsulays BB; Aodah AH; Ahmed MM; Anwer MK Int J Nanomedicine; 2024; 19():3461-3473. PubMed ID: 38617799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]